Report: A 22-year-old female presented with neck pain, which was worse at night and recumbency, and intermittent paresthesia in upper limbs. MRI revealed an intramedullary cervical tumour with a syrinx within the upper cervical cord and medulla. Total resection of tumour with laminoplasty and duraplasty was done. Pathology confirmed ganglioglioma of the spinal cord. A year after surgery, the patient has no complaint. Physical exam reveals no abnormality. MRI with contrast reveals no recurrence. Conclusion: No general consensus exists on the management of intramedullary spinal ganglioglioma. MRI might be non-specific; however, some may be characteristic to differentiate it from other intramedullary tumours. The tumour responds optimally to resection, and every attempt should be made to perform a total surgical resection. The role of adjuvant therapy remains controversial.
Introduction
Ganglioglioma contains both neoplastic astrocytes and neural cells. 1 It is a rare tumour constituting 0.4-6.25% of all primary central nervous system (CNS) neoplasms. 1 Ganglioglioma may occur throughout CNS, predominantly in the supratentorial area. Spinal cord ganglioglioma is a very rare entity (1% of all intramedullary tumours). 1 Radiological characteristics and therapeutic interventions are matters of controversy.
Case report
A 22-year-old female presented with neck pain, paresthesia in the upper limbs, mild quadriparesis (4/5), increased deep tendon reflexes (3 þ ) in four limbs and Hoffmann and Babinski signs.
Magnetic Resonance Imaging (MRI) revealed an intramedullary cervical tumour with a syrinx extending to the medulla ( Figure 1 ). The tumour was of mixed signal intensities on T1 and hyperintense on T2. Homogeneous enhancement was evident (Figure 1 ).
Bilateral open door laminoplasty was performed. Dura was opened in the midline and the oedematous cord appeared.
After midline myelotomy, a dark red tumour with relatively few vessels appeared. Despite a well-defined border, the tumour was adhesive to the normal cord and resected gross totally under surgical microscope. Dura was closed tightly without myeloplasty. Laminoplasty was done applying titanium microplates.
Histopathological exam revealed ganglion cells with astrocytic components, in favour of ganglioglioma. (Figure 2 ). MIB-1 was positive.
Postoperatively, weakness became more severe in the right arm and leg (I/V and II/V, respectively). The patient was able to walk on the second day. After the fourth day, arm weakness gradually improved and she was discharged and referred to a physical therapist on the sixth day. Six months later, the patient was able to write and the force of the four limbs became 4/5. MRI with contrast showed no obvious mass lesion (Figure 3 ).
Discussion
Ganglioglioma was first introduced as a CNS neoplasm by Ewing in 1928. Only 1.1% of all spinal tumours show this pathology.
The most commonly affected areas are the temporal lobe and cerebellum and the least affected is the spinal cord with a predilection for the cervical regionF (Table 1) .
Children are more affected than adults. No gender predominance is seen for spinal tumours. 1 The most common presenting symptom is back pain and limb weakness. Spinal lesions are found earlier than cerebral lesions.
Radiological characteristics are not pathogenomic. 1 MRI is the diagnostic modality of choice. Ganglioglioma might be hyperintense, isointense, hypointense or heterogeneous on T1; it is mostly hyperintense on T2 and mostly enhances heterogeneously with contrast. Total surgical resection remains the standard treatment. Preoperative radiological presumption of ganglioglioma is of clinical importance. Usually, more than eight segments of the spinal cord are involved, and its length is two times that of astrocytoma and ependymoma. Holospinal involvement, scoliosis and bone remodelling, mixed intensity on T1, significant cysts or syrinx, absence of oedema and enhancement within the tumour centre, hemosiderin or calcification and young age help in diagnosis. 2 The higher intensity of fluid contents of cysts, irregular margins with soft tissue compartment and gadolinium enhancement help in differentiating them from syrinx. The literature only provides five cases of malignant ganglioglioma. 3 This risk is 10% for intracranial ganglioglioma, mostly within the glial component, but unclear for spinal tumours; however it is rare for cerebellar tumours. That total surgical resection is the treatment of choice for ganglioglioma is accepted (Table 1) . Early surgical intervention follows two main advantages: first, surgery with better functional status. Second, easier resection due to smaller size. Some argue that complete resection might not be feasible because no well-defined plane of cleavage could be identified. Hamburger et al. 1 believe that it carries a high morbidity rate even with microsurgical techniques. The extent of resection is the main factor to determine the outcome; however, some disagree. Surgical outcome reports include recovery, no change in neurological status, and progression of neurological deficit. 4 The recurrence is more in spinal ganglioglioma than in cerebral counterparts. 4 Close follow-up is necessary. It is suggested that patients be seen every 6 months for 2 years postoperatively, and annually thereafter. Routine radiotherapy is not suggested; 1 however, no clinical trial exists. The reasons include the risk of differentiation of the astrocytic component into glioblastoma (Table 1) , the probability of irradiation necrosis and neurological compromise. Radiotherapy is considered for cases in which the radical resection of tumour is not feasible, when progression is evident and for malignant histolopathology. The role of chemotherapy remains indefinite. In recurrence, surgery should be considered; however, radiotherapy might be another option. After the second surgery, adjuvant therapy should be considered. 5 
Conclusion
Intramedullary spinal ganglioglioma is a rarely discussed entity. MRI findings might be non-specific. Some characteristics may help in differentiation and are useful in planning the surgery. Total resection is the standard treatment. The role of adjuvant therapy remains controversial. 
